Compare AVB & DGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AVB | DGX |
|---|---|---|
| Founded | 1978 | 1967 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical Specialities |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.1B | 20.5B |
| IPO Year | 1994 | 1996 |
| Metric | AVB | DGX |
|---|---|---|
| Price | $181.20 | $182.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 15 | 15 |
| Target Price | ★ $208.90 | $194.07 |
| AVG Volume (30 Days) | 985.1K | ★ 1.1M |
| Earning Date | 10-29-2025 | 10-21-2025 |
| Dividend Yield | ★ 3.86% | 1.75% |
| EPS Growth | 12.03 | ★ 14.49 |
| EPS | 8.20 | ★ 8.51 |
| Revenue | $3,065,608,000.00 | ★ $10,850,000,000.00 |
| Revenue This Year | $3.39 | $12.37 |
| Revenue Next Year | $4.57 | $3.51 |
| P/E Ratio | $22.09 | ★ $21.43 |
| Revenue Growth | 6.50 | ★ 13.74 |
| 52 Week Low | $166.73 | $148.70 |
| 52 Week High | $234.54 | $197.55 |
| Indicator | AVB | DGX |
|---|---|---|
| Relative Strength Index (RSI) | 52.05 | 47.10 |
| Support Level | $180.08 | $184.18 |
| Resistance Level | $183.60 | $193.35 |
| Average True Range (ATR) | 2.42 | 3.51 |
| MACD | 0.78 | -0.28 |
| Stochastic Oscillator | 68.31 | 16.06 |
AvalonBay Communities owns a portfolio of 295 apartment communities with almost 90,000 units and is developing 20 additional properties with approximately 7,300 units. The company focuses on owning large, high-quality properties in major metropolitan areas of New England, New York/New Jersey, Washington, D.C., California, and the Pacific Northwest.
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 95% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,300 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.